Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127723581 | 12772358 | 1 | I | 20160912 | 20160922 | 20160922 | EXP | IT-MINISAL02-374090 | IT-MYLANLABS-2016M1039473 | MYLAN | CECCARELLI G, GHEZZI MC, RAPONI G, BRUNETTI G, MARSIGLIA C, FALLANI S, ET AL.. VORICONAZOLE TREATMENT OF CANDIDA TROPICALIS MENINGITIS: PERSISTENCE OF (1,3)-BETA-D- GLUCAN IN THE CEREBROSPINAL FLUID IS A MARKER OF CLINICAL AND MICROBIOLOGICAL FAILURE: A CASE REPORT.. MEDICINE. 2016;95 (31):E4474 | 0.00 | Y | 0.00000 | 20160922 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127723581 | 12772358 | 1 | PS | VORICONAZOLE. | VORICONAZOLE | 1 | Intravenous (not otherwise specified) | 12 MG DAILY | N | 90547 | 12 | MG | INJECTION | QD | |||||
| 127723581 | 12772358 | 2 | SS | FLUCONAZOLE MYLAN | FLUCONAZOLE | 1 | 400 MG DAILY | U | U | 0 | 400 | MG | QD | ||||||
| 127723581 | 12772358 | 3 | SS | AMPHOTERICIN B, LIPOSOME | AMPHOTERICIN B | 1 | 3 MG/KG DAILY | U | U | 0 | 3 | MG/KG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127723581 | 12772358 | 1 | Meningitis candida |
| 127723581 | 12772358 | 2 | Meningitis candida |
| 127723581 | 12772358 | 3 | Meningitis candida |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127723581 | 12772358 | DE |
| 127723581 | 12772358 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127723581 | 12772358 | Bacterial sepsis | |
| 127723581 | 12772358 | Condition aggravated | |
| 127723581 | 12772358 | Meningitis | |
| 127723581 | 12772358 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |